BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29413655)

  • 1. A Diagnostic Approach to Fibroepithelial Breast Lesions.
    Tan BY; Tan PH
    Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
    Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
    Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
    Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
    Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
    Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
    Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
    BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroadenoma With Pleomorphic Stromal Giant Cells: It's Not as Bad as It Looks!
    Wawire J; Singh K; Steinhoff MM
    Int J Surg Pathol; 2017 Aug; 25(5):425-427. PubMed ID: 28413897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
    Aiyer HM; Jain M; Thomas S; Logani KB
    Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
    Resetkova E; Khazai L; Albarracin CT; Arribas E
    Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periductal Stromal Tumor of the Breast with a
    Anderson B; Marotti JD; Lefferts JA; Muller KE
    Int J Surg Pathol; 2023 Dec; 31(8):1626-1631. PubMed ID: 36823780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
    Lee A; James J; Whisker L; Rakha EA; Ellis IO
    Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
    Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
    Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent challenges in the evaluation of fibroepithelial lesions.
    Giri D
    Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
    Seow DYB; Tay TKY; Tan PH
    Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
    Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
    Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.
    Abdulcadir D; Nori J; Meattini I; Giannotti E; Boeri C; Vanzi E; Vezzosi V; Bianchi S
    Eur J Surg Oncol; 2014 Jul; 40(7):859-64. PubMed ID: 24612651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
    Lien HC; Huang CS; Yang YW; Jeng YM
    Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
    Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
    Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.